Cargando…

Clinicopathological Significance of MTA 1 Expression in Patients with Non-Small Cell Lung Cancer: A Meta-Analysis

BACKGROUND: Metastasis associated gene 1(MTA1) is one of the most deregulated molecules in human cancer and leads to cancer progression and metastasis. We performed a meta-analysis to determine the correlations between MTA1 expression and the clinicopathological characteristics of non-small cell lun...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhu, Wei, Li, Guixian, Guo, Haina, Chen, Honglang, Xu, Xiujuan, Long, Jiali, Zeng, Chao, Wang, Xiaojun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	West Asia Organization for Cancer Prevention 2017
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5773769/ https://www.ncbi.nlm.nih.gov/pubmed/29172257 http://dx.doi.org/10.22034/APJCP.2017.18.11.2903

Ejemplares similares

Clinicopathological and prognostic significance of Nanog expression in non-small cell lung cancer: a meta-analysis
por: Huang, Guichuan, et al.
Publicado: (2019)

Clinicopathological significance of CXCR4 in non-small cell lung cancer
por: Zhou, Xiao-ming, et al.
Publicado: (2015)

Clinicopathological Significance of RUNX1 in Non-Small Cell Lung Cancer
por: Kim, Yujin, et al.
Publicado: (2020)

Prognostic and clinicopathological significance of Beclin-1 in non-small-cell lung cancer: a meta-analysis
por: Zheng, Tianliang, et al.
Publicado: (2018)

MTA1 promotes epithelial to mesenchymal transition and metastasis in non-small-cell lung cancer
por: Ma, Ke, et al.
Publicado: (2017)

Overexpression of MTA3 Correlates with Tumor Progression in Non-Small Cell Lung Cancer
por: Li, Haiying, et al.
Publicado: (2013)

Clinicopathological significance of oestrogen receptor expression in non-small cell lung cancer
por: Chen, Xiang-Qi, et al.
Publicado: (2016)

Prognostic and Clinicopathological Significance of Downregulated E-Cadherin Expression in Patients with Non-Small Cell Lung Cancer (NSCLC): A Meta-Analysis
por: Yang, Yan-Long, et al.
Publicado: (2014)

The clinicopathological significance of FHIT hypermethylation in non-small cell lung cancer, a meta-analysis and literature review
por: Yan, Wei, et al.
Publicado: (2016)

Clinicopathological significance of CHFR methylation in non-small cell lung cancer: a systematic review and meta-analysis
por: Wang, Chen, et al.
Publicado: (2017)

Prognostic and clinicopathological significance of NRF2 expression in non-small cell lung cancer: A meta-analysis
por: Wang, Qingsong, et al.
Publicado: (2020)

Clinicopathological significance and prognostic value of E-cadherin expression in non-small cell lung cancer: A protocol for systematic review and meta-analysis
por: Chao, Dong, et al.
Publicado: (2021)

MTA1 promotes the invasion and migration of non-small cell lung cancer cells by downregulating miR-125b
por: Li, Yiyi, et al.
Publicado: (2013)

Clinicopathological significance of fascin-1 expression in patients with non-small cell lung cancer
por: Ling, Xiao-Ling, et al.
Publicado: (2015)

Clinicopathological significance and potential drug target of RUNX3 in non-small cell lung cancer: a meta-analysis
por: Xu, Lijun, et al.
Publicado: (2015)

Clinicopathological significance of DAPK promoter methylation in non-small-cell lung cancer: a systematic review and meta-analysis
por: Zhang, Yan, et al.
Publicado: (2018)

Clinicopathological and prognostic significance of SMAD4 in non-small cell lung cancer: A meta-analysis and database validation
por: Li, Zhiqiang, et al.
Publicado: (2023)

MTA1-TJP1 interaction and its involvement in non-small cell lung cancer metastasis
por: Wang, Wei, et al.
Publicado: (2022)

The clinicopathological significance and ethnic difference of FHIT hypermethylation in non-small-cell lung carcinoma: a meta-analysis and literature review
por: Wu, Xiaoyu, et al.
Publicado: (2016)

The clinicopathological significance of hMLH1 hypermethylation in non-small-cell lung cancer: a meta-analysis and literature review
por: Han, Yi, et al.
Publicado: (2016)

Clinicopathological and prognostic significance of regulatory T cells in patients with non-small cell lung cancer: A systematic review with meta-analysis
por: Zhao, Sha, et al.
Publicado: (2016)

Prognostic and clinicopathological significance of nm23-H1 expression in non-small cell lung cancer: A meta-analysis
por: Li, Dailong, et al.
Publicado: (2022)

Prognostic value and clinicopathological significance of epithelial cadherin expression in non-small cell lung cancer
por: Qiu, Zhi-Xin, et al.
Publicado: (2015)

Clinicopathological significance of p14(ARF) expression in lung cancer: a meta-analysis
por: Wang, Fang, et al.
Publicado: (2017)

Comparison of Rat Connective Tissue Response to BioMTA, Angelus MTA, and Root MTA
por: Alimohammadi, Marzieh, et al.
Publicado: (2021)

Expression and Clinicopathological Significance of SOX11 in Small-Cell Lung Cancer
por: Xinli, Wang, et al.
Publicado: (2022)

Clinicopathological and prognostic significance of NM23 expression in patients with non-small cell lung cancer: A systematic review and meta-analysis
por: Min, Shi-hui, et al.
Publicado: (2021)

Clinicopathological significance of non-small cell lung cancer with high prevalence of Oct-4 tumor cells
por: Chen, Zhenguang, et al.
Publicado: (2012)

Clinicopathological significance of KAI1 expression and epithelial-mesenchymal transition in non-small cell lung cancer
por: Zhou, Lei, et al.
Publicado: (2015)

The Clinicopathological Significance of MicroRNA-155 in Breast Cancer: A Meta-Analysis
por: Zeng, Hui, et al.
Publicado: (2014)

Clinicopathological significance and a potential drugtarget of RARβ in non-small-cell lung carcinoma: a meta-analysis and a systematic review
por: Song, Xiaoyun, et al.
Publicado: (2016)

Prognostic and clinicopathological significance of long noncoding RNA MALAT-1 expression in patients with non-small cell lung cancer: A meta-analysis
por: Liu, Xiaoli, et al.
Publicado: (2020)

The clinicopathological and prognostic significance of mTOR and p-mTOR expression in patients with non-small cell lung cancer: A meta-analysis
por: Qiu, Weiwei, et al.
Publicado: (2022)

MTA1 Expression Can Stratify the Risk of Patients with Multifocal Non-Small Cell Lung Cancers ≤3 cm
por: Wang, Wei, et al.
Publicado: (2021)

Comparison of Antibacterial Activities of ProRoot MTA, OrthoMTA, and RetroMTA Against Three Anaerobic Endodontic Bacteria
por: Khedmat, Sedigheh, et al.
Publicado: (2018)

Prognostic Values of Vimentin Expression and Its Clinicopathological Significance in Non-Small Cell Lung Cancer: A Meta-Analysis of Observational Studies with 4118 Cases
por: Ye, Zhihua, et al.
Publicado: (2016)

Deconvolution of the particle size distribution of ProRoot MTA and MTA Angelus
por: Ha, William Nguyen, et al.
Publicado: (2016)

Evaluation of the cytotoxic effects of a new Harvard MTA compared to MTA Flow and ProRoot MTA on human gingival fibroblasts
por: Youssef, Abdel-Rahman, et al.
Publicado: (2021)

The clinicopathological significance of CDH1 in gastric cancer: a meta-analysis and systematic review
por: Zeng, Wei, et al.
Publicado: (2015)

Clinical studies with MTA.
por: Calvert, A. H., et al.
Publicado: (1998)

Cannot write session to /tmp/vufind_sessions/sess_b3m0oackkeld3n0smd2t80mbds